1887

Abstract

This report describes a case of chronic and deep pyodermitis in a 4-year-old male dog with a 3-month skin problems history that had been treated unsuccessfully with fluoroquinolone therapy, prescribed by a private medical veterinary practice, without an early diagnosis. Microbiological examination and antimicrobial susceptibility testing were performed in our laboratory (Faculty of Veterinary Medicine) and a diagnosis of -associated pyoderma in the dog was made. A new antimicrobial treatment, with tetracyclines, was designed after the definitive diagnosis and antimicrobial susceptibility testing performed by the Kirby–Bauer disc diffusion method. The dog remained free of clinical illness at completion of therapy. To our knowledge, this is the first case of a canine pyoderma caused by , a commensal organism which may also cause pyogenic infections. Furthermore, this study confirms that a fluoroquinolone represents a poor empirical choice for initial therapy of canine pyoderma.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.033845-0
2012-03-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/3/438.html?itemId=/content/journal/jmm/10.1099/jmm.0.033845-0&mimeType=html&fmt=ahah

References

  1. Barry A. L., Brown S. D., Novick W. J. 1995; In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates. Antimicrob Agents Chemother 39:2193–2196[PubMed] [CrossRef]
    [Google Scholar]
  2. Chiang W. C., Tsai J. C., Chen S. Y., Hsu C. Y., Wu C. T., Teng L. J., Hsueh P. R. 2004; Mycotic aneurysm caused by Streptococcus constellatus subsp. constellatus . J Clin Microbiol 42:1826–1828 [View Article][PubMed]
    [Google Scholar]
  3. Clarridge J. E. III, Osting C., Jalali M., Osborne J., Waddington M. 1999; Genotypic and phenotypic characterization of “Streptococcus milleri” group isolates from a Veterans Administration hospital population. J Clin Microbiol 37:3681–3687[PubMed]
    [Google Scholar]
  4. Clarridge J. E. III, Attorri S., Musher D. M., Hebert J., Dunbar S. 2001; Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (“Streptococcus milleri group”) are of different clinical importance and are not equally associated with abscess. Clin Infect Dis 32:1511–1515 [View Article][PubMed]
    [Google Scholar]
  5. CLSI 2002; Zone Diameter Interpretive Standards and Minimal Inhibitory Concentration (MIC) Breakpoints for Veterinary Pathogens; Approved Standard, 2nd edn. M31-A2. Wayne, PA: Clinical and Laboratory Standards Institute;
  6. CLSI 2008; Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standard, 3rd edn. M31-A3. Wayne, PA: Clinical and Laboratory Standards Institute;
  7. CLSI 2010; Performance Standards for Antimicrobial Susceptibility Testing, 20th Informational Supplement. M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute;
  8. Facklam R. 2002; What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15:613–630 [View Article][PubMed]
    [Google Scholar]
  9. Fuentes Olmo J., Ruiz Mariscal M., Uribarrena Amezaga R., Omiste Sanvicente T. 2006; [Spontaneous bacterial peritonitis due to Streptococcus constellatus]. Gastroenterol Hepatol 29:595–596 (in Spanish) [View Article][PubMed]
    [Google Scholar]
  10. Gross T. A., Ihrke P. J., Walder E. J., Affolter V. K. 2005; Pustular diseases of the epidermis. In Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis, 2nd edn. pp. 6–9 Oxford: Blackwell Science; [View Article]
    [Google Scholar]
  11. Kawakami T., Shibata S., Murayama N., Nagata M., Nishifuji K., Iwasaki T., Fukata T. 2010; Antimicrobial susceptibility and methicillin resistance in Staphylococcus pseudintermedius and Staphylococcus schleiferi subsp. coagulans isolated from dogs with pyoderma in Japan. J Vet Med Sci 72:1615–1619 [View Article][PubMed]
    [Google Scholar]
  12. Lamm C. G., Ferguson A. C., Lehenbauer T. W., Love B. C. 2010; Streptococcal infection in dogs: a retrospective study of 393 cases. Vet Pathol 47:387–395 [View Article][PubMed]
    [Google Scholar]
  13. Livermore D. M. 2003; Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 36:Suppl. 1S11–S23 [View Article][PubMed]
    [Google Scholar]
  14. Livermore D. M. 2005; Minimising antibiotic resistance. Lancet Infect Dis 5:450–459 [View Article][PubMed]
    [Google Scholar]
  15. MacLean R. C., Hall A. R., Perron G. G., Buckling A. 2010; The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat Rev Genet 11:405–414 [View Article][PubMed]
    [Google Scholar]
  16. Ng K. W., Mukhopadhyay A. 2009; Streptococcus constellatus bacteremia causing septic shock following tooth extraction: a case report. Cases J 2:6493 [View Article][PubMed]
    [Google Scholar]
  17. Rodrigues A. L., Soares M. C., Ramos F. L., Crociati Meguins L. 2009; Multiple pyogenic liver abscesses caused by Streptococcus constellatus in the Amazon region. Case report. Ann Hepatol 8:255–257[PubMed]
    [Google Scholar]
  18. Ruoff K. L. 1988; Streptococcus anginosus (“Streptococcus milleri”): the unrecognized pathogen. Clin Microbiol Rev 1:102–108[PubMed]
    [Google Scholar]
  19. Soulsby E. J. 2005; Resistance to antimicrobials in humans and animals. BMJ 331:1219–1220 [View Article][PubMed]
    [Google Scholar]
  20. Welsh K. J., Barlow M., Tenover F. C., Biddle J. W., Rasheed J. K., Clark L. A., McGowan J. E. Jr 2005; Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase. Antimicrob Agents Chemother 49:1242–1244 [View Article][PubMed]
    [Google Scholar]
  21. Whiley R. A., Fraser H., Hardie J. M., Beighton D. 1990; Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the “Streptococcus milleri group”. J Clin Microbiol 28:1497–1501[PubMed]
    [Google Scholar]
  22. Whiley R. A., Beighton D., Winstanley T. G., Fraser H. Y., Hardie J. M. 1992; Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 30:243–244[PubMed]
    [Google Scholar]
  23. Whitworth J. M. 1990; Lancefield group F and related streptococci. J Med Microbiol 33:135–151 [View Article][PubMed]
    [Google Scholar]
  24. Yoshida Y., Ito S., Sasaki T., Kishi M., Kurota M., Suwabe A., Kunimatsu K., Kato H. 2008; Molecular and enzymatic characterization of βC-S lyase in Streptococcus constellatus . Oral Microbiol Immunol 23:245–253 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.033845-0
Loading
/content/journal/jmm/10.1099/jmm.0.033845-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error